Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
15.42
+0.02 (0.13%)
Aug 4, 2025, 4:00 PM - Market closed
MorphoSys AG Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$32.15
Upside
+108.50%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold → Strong Sell Downgrades $24 → $14 | Hold → Strong Sell | Downgrades | $24 → $14 | -9.21% | Jul 9, 2025 |
| Truist Securities | Truist Securities | Hold Initiates $24 | Hold | Initiates | $24 | +55.64% | Jun 16, 2025 |
| Citigroup | Citigroup | Hold Maintains $20 → $24 | Hold | Maintains | $20 → $24 | +55.64% | May 22, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $58 → $59 | Strong Buy | Maintains | $58 → $59 | +282.62% | May 1, 2025 |
| Stifel | Stifel | Strong Buy Maintains $60 → $31 | Strong Buy | Maintains | $60 → $31 | +101.04% | May 1, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $22 → $20 | Hold | Maintains | $22 → $20 | +29.70% | May 1, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $36 → $30 | Buy | Maintains | $36 → $30 | +94.55% | May 1, 2025 |
| Baird | Baird | Hold Maintains $33 → $24 | Hold | Maintains | $33 → $24 | +55.64% | May 1, 2025 |
| Mizuho | Mizuho | Hold Initiates $20 | Hold | Initiates | $20 | +29.70% | Apr 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $45 → $22 | Buy → Hold | Downgrades | $45 → $22 | +42.67% | Mar 5, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $35 → $24 | Strong Buy → Hold | Downgrades | $35 → $24 | +55.64% | Mar 4, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $42 → $24 | Hold | Maintains | $42 → $24 | +55.64% | Mar 3, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $38 → $22 | Buy → Hold | Downgrades | $38 → $22 | +42.67% | Mar 3, 2025 |
| Barclays | Barclays | Buy Maintains $60 → $53 | Buy | Maintains | $60 → $53 | +243.71% | Feb 28, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $50 → $35 | Strong Buy | Maintains | $50 → $35 | +126.98% | Feb 27, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $65 → $55 | Buy | Maintains | $65 → $55 | +256.68% | Feb 27, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.